Ferreira CR, Gahl WA (2017) Lysosomal storage diseases. Transl Sci Rare Dis 2:1–71
PubMed PubMed Central Google Scholar
Solovyeva V, Shaimardanova AA, Chulpanova DS, Kitaeva KV, Chakrabarti L, Rizvanov AA (2018) New approaches to Tay-Sachs disease therapy. Front Physiol 9:1–11
Seyrantepe V, Demir SA, Timur ZK, Von Gerichten J, Marsching C, Erdemli E et al (2018) Murine Sialidase Neu3 facilitates GM2 degradation and bypass in mouse models of Tay-Sachs disease. Exp Neurol 299(2017):26–41
Article CAS PubMed Google Scholar
Clarke LA, Hollak CEM (2015) The clinical spectrum and pathophysiology of skeletal complications in lysosomal storage disorders. Best Pract Res Clin Endocrinol Metab 29:219–235
Article CAS PubMed Google Scholar
Kuiper G-A, Langereis EJ, Breyer S, Carbone M, Castelein RM, Eastwood DM et al (2019) Treatment of thoracolumbar kyphosis in patients with mucopolysaccharidosis type I: results of an international consensus procedure. Orphanet J Rare Dis 14:17
Article PubMed PubMed Central Google Scholar
Oussoren E, Brands MMMG, Ruijter GJG, van der Ploeg AT, Reuser AJJ (2011) Bone, joint, and tooth development in mucopolysaccharidoses: Relevance to therapeutic options. Biochim Biophys Acta Mol Basis Dis 1812:1542–1556
Malatt C, Koning JL, Naheedy J (2015) Skeletal and brain abnormalities in fucosidosis, a rare lysosomal storage disorder. J Radiol Case Rep 9:30–38
Article PubMed PubMed Central Google Scholar
Lebel E, Dweck A, Foldes AJ, Golowa Y, Itzchaki M, Zimran A et al (2004) Bone density changes with enzyme therapy for Gaucher disease. J Bone Miner Metab 22:597–601
Mikosch P, Hughes D (2010) An overview on bone manifestations in Gaucher disease. Wien Med Wochenschr 160:609–624
Ko AR, Jin DK, Cho SY, Park SW, Przybylska M, Yew NS et al (2016) AAV8-mediated expression of N-acetylglucosamine-1-phosphate transferase attenuates bone loss in a mouse model of mucolipidosis II. Mol Genet Metab 117:447–455
Article CAS PubMed Google Scholar
Kuehn SC, Koehne T, Cornils K, Markmann S, Riedel C, Pestka JM et al (2015) Impaired bone remodeling and its correction by combination therapy in a mouse model of mucopolysaccharidosis-I. Hum Mol Genet 24:7075–7086
Dahl M, Smith EMK, Warsi S, Rothe M, Ferraz MJ, Aerts JMFG et al (2021) Correction of pathology in mice displaying Gaucher disease type 1 by a clinically-applicable lentiviral vector. Mol Ther Methods Clin Dev 20:312–323
Article CAS PubMed Google Scholar
Toma L, Pinto W, Rodrigues VC, Dietrich CP, Nader HB (1990) Impaired sulfated glycosaminoglycan metabolism in a patient with GM-2 gangliosidosis (Tay-Sachs disease). J Inherit Metab Dis 13:721–731
Article CAS PubMed Google Scholar
Adams C, Green S (1986) Late-onset hexosaminidase A and hexosaminidase A and B deficiency: family study and review. Dev Med Child Neurol 28:236–243
Article CAS PubMed Google Scholar
Hölzer HT, Boschann F, Hennermann JB, Hahn G, Hermann A, von der Hagen M et al (2021) Cerebellar atrophy on top of motor neuron compromise as indicator of late-onset GM2 gangliosidosis. J Neurol 268:2259–2262
Article PubMed PubMed Central Google Scholar
Nardocci N, Bertagnolio B, Rumi V, Angelini L (1992) Progressive dystonia symptomatic of juvenile GM2 gangliosidosis. Mov Disord 7:64–67
Article CAS PubMed Google Scholar
Johnson WG, Wigger HJ, Karp HR, Glaubiger LM, Rowland LP (1982) Juvenile spinal muscular atrophy: A new hexosaminidase deficiency phenotype. Ann Neurol 11:11–16
Article CAS PubMed Google Scholar
Rapin I (1976) Adult (Chronic) GM2 gangliosidosis. Arch Neurol 33:120
Article CAS PubMed Google Scholar
Jeyakumar M, Smith D, Eliott-smith E, Cortina-borja M, Reinkensmeier G, Butters TD et al (2002) An inducible mouse model of late onset Tay – Sachs disease. Neurobiol Dis 10:201–210
Article CAS PubMed Google Scholar
Chung HJ, Kim WK, Oh J, Kim MR, Shin JS, Lee J et al (2017) Anti-osteoporotic activity of harpagoside by upregulation of the BMP2 and Wnt signaling pathways in osteoblasts and suppression of differentiation in osteoclasts. J Nat Prod 80:434–42
Article CAS PubMed Google Scholar
Kushwaha P, Khedgikar V, Gautam J, Dixit P, Chillara R, Verma A et al (2014) A novel therapeutic approach with Caviunin-based isoflavonoid that en routes bone marrow cells to bone formation via BMP2/Wnt-β-catenin signaling. Cell Death Dis 5:e1422–e1422
Article CAS PubMed PubMed Central Google Scholar
Bucay N, Sarosi I, Dunstan CR, Morony S, Tarpley J, Capparelli C et al (1998) osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification. Genes Dev 12:1260–1268
Article CAS PubMed PubMed Central Google Scholar
Beranger GE, Djedaini M, Battaglia S, Roux CH, Scheideler M, Heymann D, Amri EZ, Pisani DF (2015) Oxytocin reverses osteoporosis in a sex-dependent manner. Front Endocrinol (Lausanne) 6:81. https://doi.org/10.3389/fendo.2015.00081
Mucci JM, Rozenfeld P (2015) Pathogenesis of bone alterations in Gaucher disease: the role of immune system. J Immunol Res 2015:1–6
Blanqué R, Cottereaux C, Gardner CR (1998) Increases in osteocalcin after ovariectomy are amplified by LPS injection: Strain differences in bone remodelling. Gen Pharmacol: Vasc Syst 30:51–56
Kuo TR, Chen CH (2017) Bone biomarker for the clinical assessment of osteoporosis: Recent developments and future perspectives. Biomark Res 5:5–13
Konukoğlu D (2019) Bone markers. Int J Med Biochem 2:65–78
Shetty S, Kapoor N, Bondu J, Thomas N, Paul T (2016) Bone turnover markers: An emerging tool in the management of osteoporosis. Indian J Endocrinol Metab 20:846–852
Article PubMed PubMed Central Google Scholar
Vijayalekha A, Anandasadagopan SK, Pandurangan AK (2023) An overview of collagen-based composite scaffold for bone tissue engineering. Appl Biochem Biotechnol 195:4617–4636
Article CAS PubMed Google Scholar
Šromová V, Sobola D, Kaspar P (2023) A brief review of bone cell function and importance. Cells 12(21):2576. https://doi.org/10.3390/cells12212576
Yamanaka S, Johnson MD, Grinberg A, Westphal H, Crawley JN, Taniike M et al (1994) Targeted disruption of the Hexa gene results in mice with biochemical and pathologic features of Tay-Sachs disease. Proc Natl Acad Sci U S A 91:9975–9979
Article CAS PubMed PubMed Central Google Scholar
Prost S, Pesenti S, Fuentes S, Tropiano P, Blondel B (2021) Treatment of osteoporotic vertebral fractures. Orthop Traumatol Surg Res 107:102779
Kelly RR, Sidles SJ, LaRue AC (2020) Effects of neurological disorders on bone health. Front Psychol 11:1–27
Nordin BEC (1997) Calcium and osteoporosis. Nutrition 13:664–686
Article CAS PubMed Google Scholar
Tsukuba T, Sakai E, Nishishita K, Kadowaki T, Okamoto K (2017) New functions of lysosomes in bone cells. J Oral Biosci 59:92–95
Ng PY, Patricia Ribet AB, Pavlos NJ (2019) Membrane trafficking in osteoclasts and implications for osteoporosis. Biochem Soc Trans 47:639–650
留言 (0)